These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10119415)

  • 21. Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1993 Sep; 58(168):46514-23. PubMed ID: 10128335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracking and surveillance of patients with medical devices and implants.
    Morgan RW
    Med Device Technol; 1993; 4(1):38-43. PubMed ID: 10171686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Device manufacturers fear FDA product tracking rules to be a heavy financial burden.
    Wagner M
    Mod Healthc; 1992 Apr; 22(15):26. PubMed ID: 10117278
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The FDA moves to implement the Safe Medical Devices Act.
    Tamborlane T
    Healthspan; 1992 Nov; 9(10):7-10. PubMed ID: 10122957
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(17):4112-21. PubMed ID: 11010653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AHA comments to FDA on Safe Devices Act.
    DePorter J
    Mater Manag Health Care; 1992 Apr; 1(2):18-21. PubMed ID: 10125489
    [No Abstract]   [Full Text] [Related]  

  • 28. Life-threatening malfunction of implantable cardiac devices.
    Myerburg RJ; Feigal DW; Lindsay BD
    N Engl J Med; 2006 Jun; 354(22):2309-11. PubMed ID: 16702187
    [No Abstract]   [Full Text] [Related]  

  • 29. High quality performance of pacemakers and implantable defibrillators.
    Levine PA; Stanton MS; Sims JJ
    Pacing Clin Electrophysiol; 2002 Dec; 25(12):1667-9. PubMed ID: 12520665
    [No Abstract]   [Full Text] [Related]  

  • 30. Postmortem analysis and retrieval of implantable pacemakers and defibrillators.
    Kirkpatrick JN; Burke MC; Knight BP
    N Engl J Med; 2006 Apr; 354(15):1649-50. PubMed ID: 16611964
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical device reporting: issues with Class III medical devices.
    Zigler J; Walsh J; Zigler J
    Food Drug Law J; 2007; 62(3):573-80. PubMed ID: 17915398
    [No Abstract]   [Full Text] [Related]  

  • 32. Act requires facilities to file reports on medical devices.
    Franke DS
    Provider; 1992 Feb; 18(2):38-9. PubMed ID: 10119637
    [No Abstract]   [Full Text] [Related]  

  • 33. Hospitals wary of interpretation of medical device reporting law.
    Burke M
    Hospitals; 1991 Oct; 65(20):40, 42. PubMed ID: 1916713
    [No Abstract]   [Full Text] [Related]  

  • 34. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical devices act means more paperwork.
    Patterson P
    OR Manager; 1991 Mar; 7(3):18-9. PubMed ID: 10109904
    [No Abstract]   [Full Text] [Related]  

  • 36. Advice for users on compliance with Devices Act.
    Patterson P
    OR Manager; 1991 May; 7(5):1, 14-5. PubMed ID: 10110590
    [No Abstract]   [Full Text] [Related]  

  • 37. New medical devices reporting requirements.
    Carley MM
    Contemp Longterm Care; 1991 Dec; 14(12):66, 68. PubMed ID: 10117951
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA working to ensure the safety of medical devices used in the pediatric population.
    Flack MN; Gross TP; Reid JS; Mills TT; Francis J
    Pediatr Clin North Am; 2012 Dec; 59(6):1355-66. PubMed ID: 23116531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in regulating breakthrough medical devices.
    Muni NI; Gross TP; Boam AB; Wang S; Zuckerman BD
    Food Drug Law J; 2005; 60(2):137-42. PubMed ID: 16097092
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical devices post-approval studies program: vision, strategies, challenges and opportunities.
    Marinac-Dabic D; Bonhomme M; Loyo-Berrios N; Gross T; Ciperson R; Gardner S; Marcarelli M
    Food Drug Law J; 2007; 62(3):597-604. PubMed ID: 17915402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.